Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging

Ken Ichiro Matsumoto, Toshihide Yamasaki, Mizuki Nakamura, Junji Ishikawa, Megumi Ueno, Ikuo Nakanishi, Aiko Sekita, Yoshikazu Ozawa, Tadashi Kamada, Ichio Aoki, Ken-Ichi Yamada

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Purpose: The detailed in vivo T1-weighted contrasting abilities of nitroxyl contrast agents, which have been used as redox responsive contrast agents in several magnetic resonance-based imaging modalities, in mouse brain were investigated. Methods: Distribution and pharmacokinetics of five types of five-membered-ring nitroxyl radical compound were compared using T1-weighted MRI. Results: The blood–brain barrier (BBB) -impermeable 3-carboxy-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CxP) could not be distributed in the brain. The slightly lipophilic 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP) showed slight distribution only in the ventricle, but not in the medulla and cortex. The amphiphilic 3-methoxy-carbonyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl (MCP) had good initial uniform distribution in the brain and showed typical 2-phase signal decay profiles. A brain-seeking nitroxyl probe, acetoxymethyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl-3-carboxylate (CxP-AM), showed an accumulating phase, and then its accumulation was maintained in the medulla and ventricle regions, but not in the cortex. The lipophilic 4-(N-methyl piperidine)−2,2,5,5-tetramethylpyrroline-N-oxyl (23c) was well distributed in the cortex and medulla, but slightly in the ventricle, and showed relatively rapid linear signal decay. Conclusion: Nitroxyl contrast agents equipped with a suitable lipophilic substitution group could be BBB-permeable functional contrast agents. MR redox imaging, which can estimate not only the redox characteristics but also the detailed distribution of the contrast agents, is a good candidate for a theranostic tool. Magn Reson Med 76:935–945, 2016.

元の言語英語
ページ(範囲)935-945
ページ数11
ジャーナルMagnetic Resonance in Medicine
76
発行部数3
DOI
出版物ステータス出版済み - 9 1 2016

Fingerprint

Contrast Media
Oxidation-Reduction
Magnetic Resonance Imaging
Brain
Pharmacokinetics
nitroxyl
pyrrolidine

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

これを引用

Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging. / Matsumoto, Ken Ichiro; Yamasaki, Toshihide; Nakamura, Mizuki; Ishikawa, Junji; Ueno, Megumi; Nakanishi, Ikuo; Sekita, Aiko; Ozawa, Yoshikazu; Kamada, Tadashi; Aoki, Ichio; Yamada, Ken-Ichi.

:: Magnetic Resonance in Medicine, 巻 76, 番号 3, 01.09.2016, p. 935-945.

研究成果: ジャーナルへの寄稿記事

Matsumoto, KI, Yamasaki, T, Nakamura, M, Ishikawa, J, Ueno, M, Nakanishi, I, Sekita, A, Ozawa, Y, Kamada, T, Aoki, I & Yamada, K-I 2016, 'Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging', Magnetic Resonance in Medicine, 巻. 76, 番号 3, pp. 935-945. https://doi.org/10.1002/mrm.25918
Matsumoto, Ken Ichiro ; Yamasaki, Toshihide ; Nakamura, Mizuki ; Ishikawa, Junji ; Ueno, Megumi ; Nakanishi, Ikuo ; Sekita, Aiko ; Ozawa, Yoshikazu ; Kamada, Tadashi ; Aoki, Ichio ; Yamada, Ken-Ichi. / Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging. :: Magnetic Resonance in Medicine. 2016 ; 巻 76, 番号 3. pp. 935-945.
@article{a81eda14f36f42c89280920fe4cb21ed,
title = "Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging",
abstract = "Purpose: The detailed in vivo T1-weighted contrasting abilities of nitroxyl contrast agents, which have been used as redox responsive contrast agents in several magnetic resonance-based imaging modalities, in mouse brain were investigated. Methods: Distribution and pharmacokinetics of five types of five-membered-ring nitroxyl radical compound were compared using T1-weighted MRI. Results: The blood–brain barrier (BBB) -impermeable 3-carboxy-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CxP) could not be distributed in the brain. The slightly lipophilic 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP) showed slight distribution only in the ventricle, but not in the medulla and cortex. The amphiphilic 3-methoxy-carbonyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl (MCP) had good initial uniform distribution in the brain and showed typical 2-phase signal decay profiles. A brain-seeking nitroxyl probe, acetoxymethyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl-3-carboxylate (CxP-AM), showed an accumulating phase, and then its accumulation was maintained in the medulla and ventricle regions, but not in the cortex. The lipophilic 4-(N-methyl piperidine)−2,2,5,5-tetramethylpyrroline-N-oxyl (23c) was well distributed in the cortex and medulla, but slightly in the ventricle, and showed relatively rapid linear signal decay. Conclusion: Nitroxyl contrast agents equipped with a suitable lipophilic substitution group could be BBB-permeable functional contrast agents. MR redox imaging, which can estimate not only the redox characteristics but also the detailed distribution of the contrast agents, is a good candidate for a theranostic tool. Magn Reson Med 76:935–945, 2016.",
author = "Matsumoto, {Ken Ichiro} and Toshihide Yamasaki and Mizuki Nakamura and Junji Ishikawa and Megumi Ueno and Ikuo Nakanishi and Aiko Sekita and Yoshikazu Ozawa and Tadashi Kamada and Ichio Aoki and Ken-Ichi Yamada",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/mrm.25918",
language = "English",
volume = "76",
pages = "935--945",
journal = "Magnetic Resonance in Medicine",
issn = "0740-3194",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Brain contrasting ability of blood-brain-barrier–permeable nitroxyl contrast agents for magnetic resonance redox imaging

AU - Matsumoto, Ken Ichiro

AU - Yamasaki, Toshihide

AU - Nakamura, Mizuki

AU - Ishikawa, Junji

AU - Ueno, Megumi

AU - Nakanishi, Ikuo

AU - Sekita, Aiko

AU - Ozawa, Yoshikazu

AU - Kamada, Tadashi

AU - Aoki, Ichio

AU - Yamada, Ken-Ichi

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Purpose: The detailed in vivo T1-weighted contrasting abilities of nitroxyl contrast agents, which have been used as redox responsive contrast agents in several magnetic resonance-based imaging modalities, in mouse brain were investigated. Methods: Distribution and pharmacokinetics of five types of five-membered-ring nitroxyl radical compound were compared using T1-weighted MRI. Results: The blood–brain barrier (BBB) -impermeable 3-carboxy-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CxP) could not be distributed in the brain. The slightly lipophilic 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP) showed slight distribution only in the ventricle, but not in the medulla and cortex. The amphiphilic 3-methoxy-carbonyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl (MCP) had good initial uniform distribution in the brain and showed typical 2-phase signal decay profiles. A brain-seeking nitroxyl probe, acetoxymethyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl-3-carboxylate (CxP-AM), showed an accumulating phase, and then its accumulation was maintained in the medulla and ventricle regions, but not in the cortex. The lipophilic 4-(N-methyl piperidine)−2,2,5,5-tetramethylpyrroline-N-oxyl (23c) was well distributed in the cortex and medulla, but slightly in the ventricle, and showed relatively rapid linear signal decay. Conclusion: Nitroxyl contrast agents equipped with a suitable lipophilic substitution group could be BBB-permeable functional contrast agents. MR redox imaging, which can estimate not only the redox characteristics but also the detailed distribution of the contrast agents, is a good candidate for a theranostic tool. Magn Reson Med 76:935–945, 2016.

AB - Purpose: The detailed in vivo T1-weighted contrasting abilities of nitroxyl contrast agents, which have been used as redox responsive contrast agents in several magnetic resonance-based imaging modalities, in mouse brain were investigated. Methods: Distribution and pharmacokinetics of five types of five-membered-ring nitroxyl radical compound were compared using T1-weighted MRI. Results: The blood–brain barrier (BBB) -impermeable 3-carboxy-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CxP) could not be distributed in the brain. The slightly lipophilic 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-N-oxyl (CmP) showed slight distribution only in the ventricle, but not in the medulla and cortex. The amphiphilic 3-methoxy-carbonyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl (MCP) had good initial uniform distribution in the brain and showed typical 2-phase signal decay profiles. A brain-seeking nitroxyl probe, acetoxymethyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl-3-carboxylate (CxP-AM), showed an accumulating phase, and then its accumulation was maintained in the medulla and ventricle regions, but not in the cortex. The lipophilic 4-(N-methyl piperidine)−2,2,5,5-tetramethylpyrroline-N-oxyl (23c) was well distributed in the cortex and medulla, but slightly in the ventricle, and showed relatively rapid linear signal decay. Conclusion: Nitroxyl contrast agents equipped with a suitable lipophilic substitution group could be BBB-permeable functional contrast agents. MR redox imaging, which can estimate not only the redox characteristics but also the detailed distribution of the contrast agents, is a good candidate for a theranostic tool. Magn Reson Med 76:935–945, 2016.

UR - http://www.scopus.com/inward/record.url?scp=84982261516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982261516&partnerID=8YFLogxK

U2 - 10.1002/mrm.25918

DO - 10.1002/mrm.25918

M3 - Article

VL - 76

SP - 935

EP - 945

JO - Magnetic Resonance in Medicine

JF - Magnetic Resonance in Medicine

SN - 0740-3194

IS - 3

ER -